# 116-hr-6155: To amend the Biologics Price Competition and Innovation Act of 2009 to make improvements with respect to the transition of biological products, and for other purposes.

116-hr-6155, To amend the Biologics Price Competition and Innovation Act of 2009 to make improvements with respect to the transition of biological products, and for other purposes., is a 116th Congress bill sponsored by Rep. Grothman, Glenn [R-WI-6] (R-WI); status Referred to the House Committee on Energy and Commerce. (as of 2025-11-18).

- Canonical: https://policyrisk.com/legislation/116-hr-6155
- As of: 2025-11-18
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Bill: 116-hr-6155
- Congress: 116
- Title: To amend the Biologics Price Competition and Innovation Act of 2009 to make improvements with respect to the transition of biological products, and for other purposes.
- Status: Referred to the House Committee on Energy and Commerce.
- Introduced: 2020-03-09
- Sponsor: Rep. Grothman, Glenn [R-WI-6] (R-WI)
- Cosponsors: 0
- Policy area: Health
- Touches household money: no
- Last recorded action: 2025-11-18

## Summary

This bill requires the Food and Drug Administration (FDA) to continue to review applications for certain biological products under an earlier review process, notwithstanding recent FDA guidance. Specifically, the bill applies to applications that were filed under the earlier process on or before March 23, 2019, and were still pending on March 23, 2020. (A 2009 law established a new procedure for approving biological products but allowed certain products in an already approved product class to receive approval under the earlier procedure until March 23, 2020; subsequently, in December 2018, the FDA issued guidance stating that an application filed under the earlier procedure that is not approved by March, 23, 2020, will not be approved.)

## Related bills

- 116-hr-8801: Air America Act of 2020
- 116-hr-8702: Holding Providers Harmless From Medicare Cuts During COVID–19 Act of 2020
- 116-hr-8662: Accelerating Access to Critical Therapies for ALS Act
- 116-hr-8498: Informed Consent Act
- 116-hr-8425: To designate the facility of the United States Postal Service located at 430 South Knowles Avenue in New Richmond, Wisconsin, as the "Captain Robert C. Harmon…
- 116-hr-8353: Women’s Public Health and Safety Act

## Sources
- [116-hr-6155 on Congress.gov](https://www.congress.gov/bill/116th-congress/house-bill/6155)

## Related
- [116-hr-8801: Air America Act of 2020](https://policyrisk.com/legislation/116-hr-8801)
- [116-hr-8702: Holding Providers Harmless From Medicare Cuts During COVID–19 Act of 2020](https://policyrisk.com/legislation/116-hr-8702)
- [116-hr-8662: Accelerating Access to Critical Therapies for ALS Act](https://policyrisk.com/legislation/116-hr-8662)
- [116-hr-8498: Informed Consent Act](https://policyrisk.com/legislation/116-hr-8498)
- [116-hr-8425: To designate the facility of the United States Postal Service located at 430 So…](https://policyrisk.com/legislation/116-hr-8425)
- [116-hr-8353: Women’s Public Health and Safety Act](https://policyrisk.com/legislation/116-hr-8353)
- [All bills in Congress](https://policyrisk.com/legislation)

Source: PRIA, https://policyrisk.com/legislation/116-hr-6155 (as of 2025-11-18).